Related Experiment Video
Updated: Jun 11, 2025
08:20
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
13.9K
Thalamocortical Dysconnectivity in Treatment-Resistant Depression
Pei-Chi Tu1,2,3,4, Wei-Chen Lin1,2,5, Wan-Chen Chang1,3,6
1Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan.
Journal of Neuroscience Research
|October 5, 2024
Summary
This study reveals altered thalamocortical connectivity in treatment-resistant depression (TRD). Key brain regions show different functional connectivity (FC) patterns in TRD patients compared to healthy individuals, suggesting dysconnectivity in TRD.
Area of Science:
- Neuroscience
- Psychiatry
- Medical Imaging
Background:
- Thalamocortical connectivity is vital for cognitive and affective functions.
- The specific role of thalamocortical connectivity in treatment-resistant depression (TRD) pathophysiology is not well understood.
Purpose of the Study:
- To investigate differences in thalamocortical functional connectivity (FC) between patients with TRD and healthy controls.
- To explore the potential contribution of thalamocortical dysconnectivity to the mechanisms underlying TRD.
Main Methods:
- Resting-state functional MRI (fMRI) was employed with the bilateral thalamus as the seed region.
- 48 patients diagnosed with TRD and 48 healthy individuals participated in the study.
- Depression severity was assessed using the Montgomery-Åsberg Depression Rating Scale (MADRS).
Main Results:
- TRD patients exhibited increased FC between the thalamus and the insula and superior temporal cortex.
- Reduced FC was observed between the thalamus and the anterior paracingulate cortex and cerebellum crus II in TRD patients.
- These findings indicate significant alterations in thalamocortical network organization in TRD.
Conclusions:
- Thalamocortical dysconnectivity appears to play a significant role in the pathomechanism of TRD.
- The observed alterations in FC patterns provide insights into the neural basis of TRD.
- A larger sample size is recommended for future studies to validate these findings and enhance statistical power.
Related Concept Videos
01:05Long-term Depression
30.7K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
30.7K
01:18Depression: Overview
224
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
224
01:23Antidepressant Drugs: MAOIs and Other Agents
200
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
200
01:30Electroconvulsive Therapy
28
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
28
01:30Attention-Deficit/Hyperactivity Disorder
47
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
47